fbpx

Functional Claim “Raises the Bar for Enablement”By: Dennis Crouchon February 17, 2021 at 3:57 am Publication: Patent – Patently-O

by Dennis Crouch

Amgen v. Sanofi and Regeneron (Fed. Cir. 2021)

The decision here provides another anti-functional-limitation decision — this time rendering Amgen’s monoclonal antibody claims invalid.  Although enablement decisions traditionally differed grea  Read More>>

Categories   Patent

YouTube
LinkedIn
LinkedIn
Share